APO-CROMOLYN NASAL SPRAY 2 % — DIN 02231390
CROMOLYN SODIUM : 2 % · APOTEX INC · SPRAY · wholesale supply in Canada
Health Canada status: DORMANT
What is APO-CROMOLYN NASAL SPRAY?
APO-CROMOLYN NASAL SPRAY 2 % contains CROMOLYN SODIUM : 2 %. It is listed in the Health Canada Drug Product Database under DIN 02231390, held by APOTEX INC, supplied as SPRAY for NASAL administration. Health Canada currently lists it as dormant, status dated 04-Aug-2017. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A). This DIN is not currently being marketed in Canada, so it is sourced to order where a compliant route exists rather than held in stock.
How much does Cromoglicic Acid cost around the world?
Cromoglicic Acid is listed on 2 of the national price registers Nexara ingests. Each country publishes on a different basis, so figures are not comparable with one another — or with a Canadian wholesale price.
What a market publishes matters more than the number it publishes. Austria publishes a KVP (Kassenverkaufspreis); Czechia publishes a max producer price (ex-factory). Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.
| Market | Price basis published there | Brands | Packs listed |
|---|---|---|---|
| Austria | KVP (Kassenverkaufspreis) | 1 | 1 |
| Czechia | max producer price (ex-factory) | 1 | 1 |
2 pack listings across 2 brand entries and 2 price bases, refreshed 03 Sep 2026. Ranges span every Cromoglicic Acid pack in that market, so a high figure is usually a larger pack rather than the same product.
Canada publishes no comparable public list price. For a delivered Canadian price on a licensed account, verify your licence — it takes about a minute.
Is there a generic Cromoglicic Acid in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
5 holders have a Canadian DIN containing Cromoglicic Acid, across 5 DINs, of which 0 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| APOTEX INC | 1 | 0 | APO-CROMOLYN NASAL SPRAY | No marketed DIN |
| GENPHARM ULC | 1 | 0 | GEN-CROMOLYN NASAL SPRAY | No marketed DIN |
| NU-PHARM INC | 1 | 0 | NU-CROMOLYN | No marketed DIN |
| PENDOPHARM DIVISION OF PHARMASCIENCE INC | 1 | 0 | RHINARIS-CS ANTI-ALLERGIC NASAL MIST | No marketed DIN |
| RHONE-POULENC RORER CANADA INC. | 1 | 0 | RYNACROM SOLUTION 2% | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 2 % |
|---|---|
| Dosage form | SPRAY |
| Route | NASAL |
Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
Substance and classification
| Active substance | Cromoglicic Acid |
|---|---|
| ATC code | R01AC01 |
| AHFS class | 48:10.32 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 02231390 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2231390 |
| Brand name | APO-CROMOLYN NASAL SPRAY |
| Generic / active ingredient | CROMOLYN SODIUM : 2 % |
| Market authorization holder | APOTEX INC |
| Health Canada schedule | NON-PRESCRIPTION DRUGS |
| ATC code | R01AC01 |
| ATC anatomical main group | R — Respiratory system |
| ATC therapeutic subgroup | R01AC |
| Current status | DORMANT |
| Status date | 04-Aug-2017 |
| Original market date | 1997-07-28 00:00:00 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
0 of 5 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| GEN-CROMOLYN NASAL SPRAY | 2 % | METERED-DOSE AEROSOL ; SOLUTION | GENPHARM ULC | CANCELLED POST MARKET | 02231326 |
| NU-CROMOLYN | 2 % | SPRAY ; LIQUID | NU-PHARM INC | CANCELLED (UNRETURNED ANNUAL) | 02231351 |
| RHINARIS-CS ANTI-ALLERGIC NASAL MIST | 2 % | SPRAY, METERED DOSE | PENDOPHARM DIVISION OF PHARMASCIENCE INC | DORMANT | 01950541 |
| RYNACROM SOLUTION 2% | 2 % | METERED-DOSE AEROSOL | RHONE-POULENC RORER CANADA INC. | CANCELLED POST MARKET | 00605255 |
2 · Same class — other molecules in ATC R01AC
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Cromoglicic Acid | APO-CROMOLYN NASAL SPRAY · GEN-CROMOLYN NASAL SPRAY · NU-CROMOLYN · RHINARIS-CS ANTI-ALLERGIC NASAL MIST · +1 more | 5 | 0 | Not in Canada |
| Levocabastine | LIVOSTIN SUS NAS 0.5MG/ML | 1 | 0 | Not in Canada |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC R01A
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| R01AD | Beclomethasone · Budesonide · Ciclesonide · Flunisolide · Fluticasone · +5 more | 55 | 24 |
| R01AA | Ephedrine · Oxymetazoline · Phenylephrine · Xylometazoline | 76 | 18 |
| R01AX | Combinations · Ipratropium Bromide · Various | 42 | 4 |
| R01AB | Ephedrine · Naphazoline · Oxymetazoline · Phenylephrine | 12 | 1 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
What else is APO-CROMOLYN NASAL SPRAY called?
Also recorded in Canada as: cromolyn sodium 5.2 MG/ACTUAT Metered Dose Nasal Spray [Nasalcrom] (US), cromolyn sodium 20 MG/ML Oral Solution [Gastrocrom] (US), cromolyn sodium 5.2 MG/ACTUAT Metered Dose Nasal Spray (US), cromolyn sodium 20 MG Inhalation Powder (US), cromolyn sodium 20 MG/ML Ophthalmic Solution (US), cromolyn sodium 20 MG/ML / xylometazoline 0.25 MG/ML Nasal Spray (US), cromolyn sodium 40 MG/ML Ophthalmic Solution (US), cromolyn sodium 10 MG/ML Inhalation Solution (US), cromolyn sodium 20 MG/ML Oral Solution (US), cromolyn sodium 100 MG Oral Capsule (US), cromolyn sodium 20 MG/ML Nasal Solution (US), cromolyn sodium 5.2 MG/ACTUAT Nasal Spray (US), CROMOLYN SODIUM (US), CROMOLYN SODIUM INHALATION (US), CROMOLYN SODIUM INHALATION SOLUTION (US).
The same molecule, Cromoglicic Acid, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| ALLERGOCROM | Latin | Czechia |
| Lomusol Nasenspray | Latin | Austria |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
How can I get it?
This DIN is dormant — it holds a Health Canada authorization but is not currently being marketed in Canada, so it cannot simply be ordered from Canadian stock. Where a patient need exists, supply may be possible through exceptional importation or the Special Access Programme, subject to Health Canada's requirements and the prescriber's application. Nexara can advise on the route and on marketed alternatives.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.